# Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting

> **NCT05772429** · — · ACTIVE_NOT_RECRUITING · sponsor: **Jazz Pharmaceuticals** · enrollment: 158 (actual)

## Conditions studied

- Seizures

## Interventions

- **DRUG:** Epidiolex

## Key facts

- **NCT ID:** NCT05772429
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-17
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05772429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05772429, "Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05772429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*